Sökresultat - Shervin Assassi

Förfina resultatet
  1. 1
    The Role of Type 1 Interferon in Systemic Sclerosis

    The Role of Type 1 Interferon in Systemic Sclerosis av Minghua Wu, Shervin Assassi

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

    Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? av Chandra Mohan, Shervin Assassi

    Publicerad 2015
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Type I interferon dysregulation in Systemic Sclerosis

    Type I interferon dysregulation in Systemic Sclerosis av Brian Skaug, Shervin Assassi

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  4. 4
    Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

    Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need av Ariane L. Herrick, Shervin Assassi, Christopher P. Denton

    Publicerad 2022
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  5. 5
    Genetics of scleroderma: implications for personalized medicine?

    Genetics of scleroderma: implications for personalized medicine? av Shervin Assassi, Timothy R. D. J. Radstake, Maureen D. Mayes, Javier Martı́n

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  6. 6
    Role of STAT3 in skin fibrosis and transforming growth factor beta signalling

    Role of STAT3 in skin fibrosis and transforming growth factor beta signalling av Mesias Pedroza, Sarah To, Shervin Assassi, Minghua Wu, David J. Tweardy, Sandeep K. Agarwal

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

    Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit av Vishal Kakkar, Shervin Assassi, Yannick Allanore, Masataka Kuwana, Christopher P. Denton, Dinesh Khanna, Francesco Del Galdo

    Publicerad 2022
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  8. 8
    Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis

    Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis av John D Pauling, Gloria A. Salazar, Hui Lu, Zoë Betteridge, Shervin Assassi, Maureen D. Mayes, Neil McHugh

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model

    Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model av Metin Akay, Yong Du, Cheryl L. Sershen, Minghua Wu, Ting Y. Chen, Shervin Assassi, Chandra Mohan, Yasemin M. Akay

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?

    Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis? av Xiaochun Liu, Maureen D. Mayes, Claudia Pedroza, Hilda T. Draeger, Emilio B. González, Brock E. Harper, John D. Reveille, Shervin Assassi

    Publicerad 2013
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease

    KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease av Gloria A. Salazar, Masataka Kuwana, Minghua Wu, Rosa M. Estrada‐Y‐Martin, Binwu Ying, Julio Charles, Maureen D. Mayes, Shervin Assassi

    Publicerad 2018
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis

    Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis av Minghua Wu, Daniel J. Schneider, Maureen D. Mayes, Shervin Assassi, Frank C. Arnett, Filemon K. Tan, Michael R. Blackburn, Sandeep K. Agarwal

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis

    Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis av Minghua Wu, Mesias Pedroza, Robert Lafyatis, A. J. George, Maureen D. Mayes, Shervin Assassi, Filemon K. Tan, Michael B. Brenner, Sandeep K. Agarwal

    Publicerad 2013
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis

    Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis av Xiaochun Liu, Maureen D. Mayes, Filemon K. Tan, Minghua Wu, John D. Reveille, Brock E. Harper, Hilda T. Draeger, Emilio B. González, Shervin Assassi

    Publicerad 2012
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis

    Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis av Hilda T. Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B. González, Brock E. Harper, Frank C. Arnett, Ameena Manzoor, Richard A. Lange, Maureen D. Mayes

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

    Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations av Pravitt Gourh, Frank C. Arnett, Shervin Assassi, Filemon K. Tan, Mei Huang, Laura Diekman, Maureen D. Mayes, John D. Reveille, Sandeep K. Agarwal

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    A one‐year, phase I/IIa, open‐label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease

    A one‐year, phase I/IIa, open‐label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease av Dinesh Khanna, Rajeev Saggar, Maureen D. Mayes, Fereidoun Abtin, Philip J. Clements, Paul Maranian, Shervin Assassi, Rajan Saggar, Ram Raj Singh, Daniel E. Furst

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis

    Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis av Rajpreet K. Arora-Singh, Shervin Assassi, Deborah J. del Junco, Frank C. Arnett, Marilyn Perry, Uzma Irfan, Roozbeh Sharif, Tony Mattar, Maureen D. Mayes

    Publicerad 2010
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects

    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects av S. Hoa, Marie Hudson, Yves Troyanov, S. Proudman, Jenny Walker, Wendy Stevens, M. Nikpour, Shervin Assassi, Maureen D. Mayes, M. Wang, Murray Baron, M J Fritzler

    Publicerad 2016
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis

    Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis av Tamar F Brionez, Shervin Assassi, John D. Reveille, Thomas J. Learch, Laura Diekman, Michael M. Ward, John C. Davis, Michael H. Weisman, Perry M. Nicassio

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: